
Stereotaxis, Inc.
NYSE · Electromedical & Electrotherapeutic Apparatus
Company Overview
A concise company profile alongside the latest public filing activity.
Stereotaxis designs and manufactures robotic magnetic navigation systems used by physicians to guide catheters during minimally invasive cardiac procedures, including treatment of arrhythmias. The company also sells related disposables, software, and imaging equipment that support these procedures in hospital electrophysiology labs.
Company profile sourced from SEC filings.
Corporate Insider Trades
Open-market purchases and sales by directors, officers, and other company insiders.
| Insider | Type | Value | Shares / Price | Date |
|---|---|---|---|---|
| Menawat Arun SwarupDirector | Buy | $100K | 121,561at $0.82 | Nov 17, 2026 |
| Benfer DavidDirector | Buy | $25K | 30,000at $0.83 | Nov 17, 2026 |
Source: SEC EDGAR Form 4 filings
Congressional Trades
Recent disclosures by members of the U.S. House and Senate.
Source: Senate eFD and House Clerk STOCK Act disclosures
Get notable STXS activity by email
Free alerts for the insider and congressional trades worth watching.
For informational purposes only, not investment advice. Filings can be delayed, corrected, or amended. Trading activity alone does not predict future performance.